We are live on ! Find out more
NIM

Northeast Investment Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 25.45%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+25.45%
3 Year Est. Return
+93.39%
5 Year Est. Return
+114.23%
10 Year Est. Return
+466.62%
AUM
$1.07B
AUM Growth
+$24.9M
Cap. Flow
-$25.3M
Cap. Flow %
-2.37%
Top 10 Hldgs %
29.53%
Holding
167
New
7
Increased
35
Reduced
87
Closed
7

Top Sells

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$5.35M
2
GILD icon
Gilead Sciences
GILD
+$4.8M
3
VFC icon
VF Corp
VFC
+$4.3M
4
TROW icon
T. Rowe Price
TROW
+$4.21M
5
CRI icon
Carter's
CRI
+$2.75M

Sector Composition

Rank Sector Weight
1 Financials 15.03%
2 Healthcare 14.83%
3 Industrials 12.43%
4 Communication Services 10.06%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
101
Cisco
CSCO
$485B
$906K 0.08%
26,804
-452
-2% -$14.7K
PM icon
102
Philip Morris
PM
$290B
$813K 0.08%
7,205
KMB icon
103
Kimberly-Clark
KMB
$35.9B
$712K 0.07%
5,411
NEE icon
104
NextEra Energy
NEE
$176B
$619K 0.06%
19,276
COP icon
105
ConocoPhillips
COP
$148B
$603K 0.06%
12,085
-585
-5% -$28.3K
IDXX icon
106
Idexx Laboratories
IDXX
$46.9B
$596K 0.06%
3,854
-100
-3% -$13.8K
VIG icon
107
Vanguard Dividend Appreciation ETF
VIG
$114B
$583K 0.05%
6,478
+2,127
+49% +$188K
BA icon
108
Boeing
BA
$184B
$576K 0.05%
3,255
MMP
109
DELISTED
Magellan Midstream Partners, L.P.
MMP
$575K 0.05%
7,481
ORCL icon
110
Oracle
ORCL
$437B
$568K 0.05%
12,736
-304
-2% -$12.7K
ABBV icon
111
AbbVie
ABBV
$436B
$562K 0.05%
8,622
-1,385
-14% -$87.1K
TRV icon
112
Travelers Companies
TRV
$78.3B
$554K 0.05%
4,596
-100
-2% -$12K
MTD icon
113
Mettler-Toledo International
MTD
$28.6B
$542K 0.05%
1,132
VGSH icon
114
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
$542K 0.05%
8,920
WMT icon
115
Walmart Inc
WMT
$893B
$542K 0.05%
22,572
-438
-2% -$10.1K
TJX icon
116
TJX Companies
TJX
$175B
$522K 0.05%
13,204
+6,504
+97% +$251K
SF
117
Stifel
SF
$12.7B
$514K 0.05%
23,029
-4,894
-18% -$113K
ATHN
118
DELISTED
Athenahealth, Inc.
ATHN
$470K 0.04%
4,175
-50
-1% -$5.83K
AMGN icon
119
Amgen
AMGN
$225B
$461K 0.04%
2,807
BND icon
120
Vanguard Total Bond Market
BND
$161B
$445K 0.04%
5,485
AGN
121
DELISTED
Allergan plc
AGN
$441K 0.04%
+1,845
New +$430K
BNY
122
Bank of New York Mellon
BNY
$108B
$414K 0.04%
8,775
QCOM icon
123
Qualcomm
QCOM
$171B
$410K 0.04%
7,152
-450
-6% -$26.1K
D icon
124
Dominion Energy
D
$59.1B
$369K 0.03%
4,753
-195
-4% -$14.8K
GLW icon
125
Corning
GLW
$137B
$351K 0.03%
13,014

Similar funds

Northeast Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Northeast Investment Management held 167 positions worth $1.07B, up 2.4% from $1.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Northeast Investment Management's Q1 2017 filing shows 7 new, 35 increased, 87 reduced and 7 closed positions. Its largest new stake was Allergan plc: 1,845 shares worth $441K. The largest sale was Manhattan Associates, an estimated $5.35M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

  • Northeast Investment Management's largest Q1 2017 buy was Allergan plc: 1,845 shares worth $441K.
  • Northeast Investment Management added most to JPMorgan Chase in Q1 2017, an estimated $3.7M increase.
  • Northeast Investment Management's biggest Q1 2017 reduction was Manhattan Associates, cutting an estimated $5.35M.
  • Northeast Investment Management fully exited Carter's in Q1 2017, selling an estimated $2.75M.
  • Northeast Investment Management's ten largest holdings make up 30% of its $1.07B portfolio in Q1 2017.
  • Northeast Investment Management opened 7 new positions and closed 7 in Q1 2017.
  • Northeast Investment Management's portfolio value rose 2.4% quarter-over-quarter to $1.07B.

Based on Northeast Investment Management's 13F filing for Q1 2017, filed 26 Apr 2017.